![Irina Antonijevic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Irina Antonijevic
Directeur/Membre du Conseil chez
4SC AG
Fortune : 37 721 $ au 30/06/2026
Profil
Irina Antonijevic currently serves as Independent Director at Biohaven Ltd. since 2022, Non-Executive Director at New Biohaven Pharmaceuticals, Inc., Non-Executive Director at Verinos Pharmaceuticals GmbH, and Member of the Supervisory Board at 4SC AG since 2012.
Former positions include Director-Translational Research at Lundbeck Research USA, Inc. from 2005 to 2009, Director-Clinical Research at Sanofi, Inc., Medical Director-Clinical Development at CHDI Foundation, Inc. from 2009 to 2010, Director at Biohaven Pharmaceutical Holding Co. Ltd., Head-Early Development Multiple Sclerosis at Genzyme Corp.
from 2011 to 2016, Member-Supervisory Board at PAION AG from 2017 to 2022, Chief Medical Officer at vasopharm GmbH from 2016 to 2017, VP-Translational Medicine & Development at Wave Life Sciences USA, Inc. from 2018 to 2019, Chief Medical Officer at Triplet Therapeutics, Inc. from 2020 to 2022, and Chief Medical Officer at EveryONE Medicines, Inc. Education includes a doctorate from The University of Edinburgh conferred in 1995, an undergraduate degree from Technische Universität München in 1991, and a doctorate from Max Planck Institute of Biochemistry in 1992.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/04/2026 | 2 535 ( 0 % ) | 37 721 $ | 30/06/2026 |
Postes actifs de Irina Antonijevic
| Sociétés | Poste | Début |
|---|---|---|
| 4SC AG | Directeur/Membre du Conseil | 06/08/2012 |
| BIOHAVEN LTD. | Directeur/Membre du Conseil | 28/09/2022 |
New Biohaven Pharmaceuticals, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Irina Antonijevic
| Sociétés | Poste | Fin |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Directeur/Membre du Conseil | 03/10/2022 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Directeur/Membre du Conseil | 03/10/2022 |
| PAION AG | Directeur/Membre du Conseil | 27/01/2022 |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Directeur Technique/Scientifique/R&D | 01/01/2022 |
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics | Corporate Officer/Principal | 01/01/2019 |
Formation de Irina Antonijevic
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
PAION AG
 PAION AG Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries develops and commercializes specialty pharmaceutical products | Health Technology |
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technische Universität München
 Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases | Health Technology |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Max Planck Institute of Biochemistry
 Max Planck Institute of Biochemistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CHDI Foundation, Inc.
 CHDI Foundation, Inc. CHDI Foundation, Inc. is a privately funded nonprofit biomedical research organization dedicated to accelerating the development of therapeutics for Huntington’s disease. The non-profit company is based in Los Angeles, CA. The foundation manages a broad portfolio of research activities, including preclinical biology, therapeutic target validation, drug development, and clinical trials. It supports Huntington’s disease research by funding academic investigators, managing internal programs through contract research organizations, and partnering with biotech and pharmaceutical companies. CHDI provides resources such as genetically modified mouse models, validated biological reagents, research tools, and a clinical biorepository with human biosamples. The foundation leads initiatives like the HD Stem Cell Initiative and maintains open-access data platforms to facilitate data sharing. CHDI operates Enroll-HD, an observational study and clinical research platform supporting clinical trial design, recruitment, and patient care. The organization also hosts scientific conferences, promotes open science policies, and engages a global network of researchers to expedite the discovery and delivery of effective Huntington’s disease treatments. | |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics | Utilities |
Triplet Therapeutics, Inc.
Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Health Services |
EveryONE Medicines, Inc.
 EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics | Commercial Services |
Biohaven Ltd.
 Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
New Biohaven Pharmaceuticals, Inc. |
